NewStream Energy Technologies (NSGP) 10-Q 11 May 17 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 11, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	Clean Coal Technologies Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		113,408,487
Amendment Flag	false
Entity Central Index Key	1,445,109
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1

Balance Sheets (Unaudited)

Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current Assets
Cash	$ 62,700	$ 100,444
Total Current Assets	62,700	100,444
Total Assets	62,700	100,444
Current Liabilities
Accounts payable	1,738,836	1,956,743
Accrued liabilities	4,331,668	3,878,460
Notes payable	463,185	463,185
Notes payable – related party	143,060	18,050
Convertible debt, net of unamortized discounts	774,419	1,397,222
Derivative liabilities	8,669,572	18,028,611
Total Current Liabilities	16,120,740	25,742,271
Long-Term Liabilities
Convertible debt, net of unamortized discounts	5,474,385	5,253,262
Total Liabilities	21,595,125	30,995,533
Stockholders’ Deficit:
Common stock, $0.00001 par value; 500,000,000 shares authorized, 111,614,695 and 101,068,451 shares issued and outstanding, respectively	1,116	1,011
Additional paid-in capital	237,186,575	235,702,112
Accumulated deficit	(258,720,116)	(266,598,212)
Total Stockholders' Deficit	(21,532,425)	(30,895,089)
Total Liabilities and Stockholders' Deficit	$ 62,700	$ 100,444

Balance Sheets (Unaudited) (Par

Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Common stock par value (in Dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	111,614,695	101,068,451
Common stock, shares outstanding	111,614,695	101,068,451

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Operating Expenses:
General and administrative	$ 438,713	$ 871,939
Research and development	0	892,093
Consulting services	4,088	4,375,298
Loss from Operations	(442,801)	(6,139,330)
Other Income (Expenses):
Interest expense	(445,421)	(390,737)
Debt extension and modification expense	(22,014)	(1,469,056)
Gain on change in fair value of derivative liabilities	8,788,332	21,974,032
Total Other Income (Expenses)	8,320,897	20,114,239
Net Income	$ 7,878,096	$ 13,974,909
Net income per share - basic (in Dollars per share)	$ 0.07	$ 0.25
Weighted average shares outstanding - basic (in Shares)	105,282,409	56,984,280
Net loss per share - diluted (in Dollars per share)	$ 0	$ (0.05)
Weighted average shares outstanding - diluted (in Shares)	206,510,723	161,097,440

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 7,878,096	$ 13,974,909
Adjustment to reconcile net income to net cash used in operating activities:
Amortization of debt discounts	231,717	239,106
Shares issued for services	0	4,991,071
(Gain) loss on change in fair value of derivative liabilities	(8,788,332)	(21,974,032)
Loss on settlement of debt	0	1,442,308
Debt extension and modification expense	22,014	77,492
Changes in operating assets and liabilities:
(Decrease) increase in accounts payable	(166,072)	40,715
Increase (decrease) in accrued expenses	442,333	(281,638)
Net Cash Used in Operating Activities	(380,244)	(1,490,069)
CASH FLOWS FROM INVESTING ACTIVITIES:	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings on convertible debt, net of original issue discounts	217,490	1,630,000
Borrowings on related party debt	130,010	0
Payments on related party debt	(5,000)	0
Payments on convertible debt	0	(246,641)
Net Cash Provided by Financing Activities	342,500	1,383,359
NET CHANGE IN CASH AND CASH EQUIVALENTS	(37,744)	(106,710)
CASH AND CASH EQUIVALENTS - beginning of period	100,444	123,066
CASH AND CASH EQUIVALENTS - end of period	62,700	16,356
SUPPLEMENTAL DISCLOSURES:
Cash paid for interest	0	37,499
Cash paid for income taxes	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Noncash Activity, Derivative Liabilities	721,178	1,177,721
Derivative liabilities recorded as debt discounts	150,471	0
Debt converted to common stock	763,390
Common stock issued for conversion of debt	763,390	0
Accrued cash restructuring fees	10,875	33,000
Accrued Wages [Member]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Debt converted to common stock	$ 0	$ 500,000

NOTE 1_ BASIS OF PRESENTATION

NOTE 1: BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2017
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1: BASIS OF PRESENTATION The accompanying unaudited interim financial statements of Clean Coal Technologies, Inc. (“Clean Coal”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in Clean Coal’s Annual Report on Form 10-K filed with the SEC. In the opinion of management, the accompanying unaudited interim financial statements reflect all adjustments, consisting of normal recurring adjustments, necessary to present fairly the financial position and the results of operations for the interim period presented herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year or for any future period. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2016 as reported in the Form 10K have been omitted. Net Income (Loss) per Common Share Basic net income (loss) per share is computed on the basis of the weighted average number of common shares outstanding during each year. Diluted net income (loss) per share is computed similar to basic net income (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. For the three months ended March 31, 2017, the dilutive effect of the outstanding warrants and warrant conversion options was 10,763,893 shares and the dilutive effect of the outstanding convertible debt was 90,464,421 shares, with a reduction to net income of $8,228,204. For the three months ended March 31, 2016, the dilutive effect of the outstanding common stock options was 0 shares, common stock warrants was 2,371,586 shares, the dilutive effect of the outstanding warrant conversion options was 30,474,522 shares and the dilutive effect of the outstanding convertible debt was 71,267,052 shares, with a reduction to net income of $21,766,902.

NOTE 2_ GOING CONCERN

NOTE 2: GOING CONCERN	3 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	NOTE 2: GOING CONCERN The accompanying financial statements have been prepared on a going concern basis of accounting which contemplates continuity of operations, realization of assets, liabilities, and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Clean Coal is unable to continue as a going concern. Clean Coal has an accumulated deficit and a working capital deficit as of March 31, 2017 with no significant revenues anticipated for the near term. Management believes Clean Coal will need to raise capital in order to operate over the next 12 months. As shown in the accompanying financial statements, Clean Coal has also incurred significant losses since inception. Clean Coal’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. Clean Coal has limited capital with which to pursue its business plan. There can be no assurance that Clean Coal’s future operations will be significant and profitable, or that Clean Coal will have sufficient resources to meet its objectives. These conditions may raise doubt as to Clean Coal’s ability to continue as a going concern. Management may pursue either debt or equity financing or a combination of both, in order to raise sufficient capital to meet Clean Coal’s financial requirements over the next twelve months and to fund its business plan. There is no assurance that management will be successful in raising additional funds.

NOTE 3_ RESEARCH AND DEVELOPMEN

NOTE 3: RESEARCH AND DEVELOPMENT	3 Months Ended
	Mar. 31, 2017
Research and Development [Abstract]
Research, Development, and Computer Software Disclosure [Text Block]	NOTE 3: RESEARCH AND DEVELOPMENT Research and development consists of costs incurred related to the construction and testing of a 2-ton/hour test plant in Oklahoma. The estimated cost of moving the test facility to a permanent location and have it reassembled is $750,000. In quarter four 2015, the test plant was commissioned and testing of the plant started. Testing was successfully completed in April 2016 and the company is currently arranging for the plant to be moved to a permanent location. During the three months ended March 31, 2017 and 2016, we incurred $0 and $892,093 in research and development expenses, respectively.

NOTE 4_ RELATED PARTY TRANSACTI

NOTE 4: RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 4: RELATED PARTY TRANSACTIONS Accruals for salary and bonuses to officers and directors are included in accrued liabilities in the balance sheets and totaled $2,757,778 and $2,660,697 as of March 31, 2017 and December 31, 2016, respectively. During the three months ended March 31, 2017, officers of the Company advanced $130,010 to the Company to cover short-term financing needs and the Company repaid an officer $5,000. The short-term loans are due on demand, do not accrue interest and are unsecured. The balance of related party short-term note was $143,060 and $18,050 as of March 31, 2017 and December 31, 2016, respectively. During the three months ended March 31, 2016, the Company granted an aggregate of 7,000,000 common shares to various employees and directors for services rendered. The aggregate fair value of these awards was determined to be $4,375,000 and it was recognized as stock compensation during the three months ended March 31, 2016. Also during the three months to March 31, 2016, the company issued 1,785,714 common shares for the conversion of $500,000 of salary due to an officer. The value of the shares was $1,116,071, of which $616,071 was recorded as additional compensation expense.

NOTE 5_ DEBT

NOTE 5: DEBT	3 Months Ended
	Mar. 31, 2017
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 5: DEBT Convertible Debt During the three months ended March 31, 2017, the Company borrowed an aggregate of $217,490, net of original issue discounts and fees of $182,856, under convertible notes payable. Additional discounts of $150,471 were recognized during the three months ended March 31, 2017 due to derivative liabilities. As of March 31, 2017 and December 31, 2016, the Company had outstanding convertible notes payable of $8,120,514 and $6,650,484, net of unamortized discounts of $1,871,710 and $1,920,571, respectively. The outstanding convertible notes of the Company are unsecured, bear interest between 6% and 12% per annum, mature between October 2017 and March 2020 and are convertible at variable rates between 60% and 65% of the quoted market price of the Company’s common stock. All notes that were convertible during the three months ended March 31, 2017 were accounted for as derivative liabilities (see Note 6). Aggregate amortization of the debt discounts on convertible debt for the three months ended March 31, 2017 and 2016 was $231,717 and $239,106, respectively. During the three months ended March 31, 2017, the Company incurred loan standstill expenses added to debt principal of $73,849. The Company also incurred a gain on settlement of accounts payable of $51,835 due to the settlement of an outstanding professional fee. Therefore, the net debt extension and modification expense is $22,014 for the three months ended March 31, 2017. During the three months ended March 31, 2017, holders of two convertible notes payable elected to convert a total of $763,390 principal into a total of 10,546,244 shares of the Company’s common stock. Nonconvertible Debt As of March 31, 2017 and December 31, 2016, the Company had outstanding notes payable to former affiliates of the Company of $463,185. These notes payable of the Company are unsecured, bear no interest and are due on demand.

NOTE 6_ DERIVATIVE LIABILITIES

NOTE 6: DERIVATIVE LIABILITIES	3 Months Ended
	Mar. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	NOTE 6: DERIVATIVE LIABILITIES During the three months ended March 31, 2017, the convertible notes issued by the Company qualified as derivative liabilities under Accounting Series Codification 815, Derivatives As of March 31, 2017 and December 31, 2016, the aggregate fair value of the outstanding derivative liabilities was $8,669,572 and $18,028,611, respectively. For the three months ended March 31, 2017 and 2016, the net gain on the change of fair value was $8,788,332 and $21,974,032, respectively. The Company estimated the fair value of the derivative liabilities using the Black-Scholes option pricing model using the following key assumptions during the three months ended March 31, 2017 Expected dividends - % Expected term (years) 0.25 – 5.00 Volatility 95% - 222 % Risk-free rate 0.50% - 1.93 % The Company determines the fair market values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The following three levels of inputs may be used to measure fair value: Level 1 Quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company uses Level 3 inputs to estimate the fair value of its derivative liabilities. The following table sets forth by level with the fair value hierarchy the Company’s assets and liabilities measured at fair value as of March 31, 2017 and December 31, 2016: Level 1 Level 2 Level 3 Total March 31, 2017: Liabilities: Derivative financial instruments $ - $ - $ 8,669,572 $ 8,669,572 December 31, 2016: Liabilities: Derivative financial instruments $ - $ - $ 18,028,611 $ 18,028,611 The below table presents the change in the fair value of the derivative liabilities during the three months ended March 31, 2017: Fair value as of December 31, 2016 $ 18,028,611 Fair value on the dates of issuance recorded as debt discounts 150,471 Extinguishment of liability to additional paid-in capital (721,178 ) Change in fair value of derivatives (8,788,332 ) Fair value as of March 31, 2017 $ 8,669,572

NOTE 7_ EQUITY TRANSACTIONS

NOTE 7: EQUITY TRANSACTIONS	3 Months Ended
	Mar. 31, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 7: EQUITY TRANSACTIONS Common Stock During the three months ended March 31, 2017, the Company issued a total of 10,546,244 shares of common stock for the conversion of $763,390 in convertible note principal. Common Stock Options A summary of common stock option activity for the three months ended March 31, 2017 is as follows: Weighted Weighted Average Average Options Exercise Price Remaining Term Outstanding - December 31, 2016 685,713 $ 4.52 2.62 Granted - - - Expired - - - Exercised - - - Outstanding – March 31, 2017 685,713 $ 4.52 2.37 Exercisable – March 31, 2017 685,713 $ 4.52 2.37 The intrinsic value of the exercisable options as of March 31, 2017 was $0. Common Stock Warrants The following table presents the common stock warrant activity during the three months ended March 31, 2017: Weighted Weighted Average Average Warrants Exercise Price Remaining Term Outstanding - December 31, 2016 7,314,423 $ 0.60 3.12 Granted 72,497 0.15 4.99 Forfeited/canceled - - - Exercised - - - Outstanding – March 31, 2017 7,386,920 $ 0.41 2.89 Exercisable – March 31, 2017 7, 386,920 $ 0.41 2.89 The intrinsic value of the exercisable warrants as of March 31, 2017 was $1,702.

NOTE 8_ SUBSEQUENT EVENTS

NOTE 8: SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 8: SUBSEQUENT EVENTS In April 2017 the Company issued a total of 164,029 common shares as final true up on a convertible note. In April 2017 the Company issued 1,800,000 common shares as part of debt conversion on a convertible note for a value of $144,000 in debt reduction. In April 2017, the outstanding lawsuit against the Company was closed out and a judgment of $121,000 was made against the company on one count and the company was found not guilty on the other two counts brought against it. This settlement has been recognized and accrued in the March 31, 2017 financials.

NOTE 6_ DERIVATIVE LIABILITIES

NOTE 6: DERIVATIVE LIABILITIES (Tables)	3 Months Ended
	Mar. 31, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	The Company estimated the fair value of the derivative liabilities using the Black-Scholes option pricing model using the following key assumptions during the three months ended March 31, 2017 Expected dividends - % Expected term (years) 0.25 – 5.00 Volatility 95% - 222 % Risk-free rate 0.50% - 1.93 %
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The following table sets forth by level with the fair value hierarchy the Company’s assets and liabilities measured at fair value as of March 31, 2017 and December 31, 2016: Level 1 Level 2 Level 3 Total March 31, 2017: Liabilities: Derivative financial instruments $ - $ - $ 8,669,572 $ 8,669,572 December 31, 2016: Liabilities: Derivative financial instruments $ - $ - $ 18,028,611 $ 18,028,611
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The below table presents the change in the fair value of the derivative liabilities during the three months ended March 31, 2017: Fair value as of December 31, 2016 $ 18,028,611 Fair value on the dates of issuance recorded as debt discounts 150,471 Extinguishment of liability to additional paid-in capital (721,178 ) Change in fair value of derivatives (8,788,332 ) Fair value as of March 31, 2017 $ 8,669,572

NOTE 7_ EQUITY TRANSACTIONS (Ta

NOTE 7: EQUITY TRANSACTIONS (Tables)	3 Months Ended
	Mar. 31, 2017
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	A summary of common stock option activity for the three months ended March 31, 2017 is as follows: Weighted Weighted Average Average Options Exercise Price Remaining Term Outstanding - December 31, 2016 685,713 $ 4.52 2.62 Granted - - - Expired - - - Exercised - - - Outstanding – March 31, 2017 685,713 $ 4.52 2.37 Exercisable – March 31, 2017 685,713 $ 4.52 2.37
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	The following table presents the common stock warrant activity during the three months ended March 31, 2017: Weighted Weighted Average Average Warrants Exercise Price Remaining Term Outstanding - December 31, 2016 7,314,423 $ 0.60 3.12 Granted 72,497 0.15 4.99 Forfeited/canceled - - - Exercised - - - Outstanding – March 31, 2017 7,386,920 $ 0.41 2.89 Exercisable – March 31, 2017 7, 386,920 $ 0.41 2.89

NOTE 1_ BASIS OF PRESENTATION (

NOTE 1: BASIS OF PRESENTATION (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
NOTE 1: BASIS OF PRESENTATION (Details) [Line Items]
Dilutive Securities, Effect on Basic Earnings Per Share (in Dollars)	$ (8,228,204)	$ (21,766,902)
Warrant [Member]
NOTE 1: BASIS OF PRESENTATION (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	10,763,893	2,371,586
Convertible Debt Securities [Member]
NOTE 1: BASIS OF PRESENTATION (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	90,464,421	71,267,052
Employee Stock Option [Member]
NOTE 1: BASIS OF PRESENTATION (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		0
Warrant Conversion Options [Member]
NOTE 1: BASIS OF PRESENTATION (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		30,474,522

NOTE 3_ RESEARCH AND DEVELOPM17

NOTE 3: RESEARCH AND DEVELOPMENT (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Research and Development [Abstract]
Estimated Cost to Move the Test Facility to Permanent Location			$ 750,000
Research and Development Expense	$ 0	$ 892,093

NOTE 4_ RELATED PARTY TRANSAC18

NOTE 4: RELATED PARTY TRANSACTIONS (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
NOTE 4: RELATED PARTY TRANSACTIONS (Details) [Line Items]
Accrued Salaries, Current	$ 2,757,778		$ 2,660,697
Proceeds from Related Party Debt	130,010	$ 0
Repayments of Related Party Debt	5,000	0
Notes Payable, Related Parties, Current	$ 143,060		$ 18,050
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	10,546,244
Debt Conversion, Original Debt, Amount	$ 763,390
Share-based Compensation	0	$ 4,991,071
Officer [Member]
NOTE 4: RELATED PARTY TRANSACTIONS (Details) [Line Items]
Proceeds from Related Party Debt	130,010
Repayments of Related Party Debt	$ 5,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		1,785,714
Debt Conversion, Original Debt, Amount		$ 500,000
Stock Issued During Period, Value, Conversion of Convertible Securities		1,116,071
Share-based Compensation		$ 616,071
Officers and Directors [Member]
NOTE 4: RELATED PARTY TRANSACTIONS (Details) [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Gross (in Shares)		7,000,000
Stock Issued During Period, Value, Share-based Compensation, Gross		$ 4,375,000

NOTE 5_ DEBT (Details)

NOTE 5: DEBT (Details)	3 Months Ended
	Mar. 31, 2017USD ($)shares	Mar. 31, 2016USD ($)	Dec. 31, 2016USD ($)
NOTE 5: DEBT (Details) [Line Items]
Proceeds from Convertible Debt	$ 217,490	$ 1,630,000
Amortization of Debt Discount (Premium)	231,717	239,106
Interest Expense, Debt	$ 22,014	1,469,056
Number of Notes Payable	2
Debt Conversion, Original Debt, Amount	$ 763,390
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	10,546,244
Convertible Debt [Member]
NOTE 5: DEBT (Details) [Line Items]
Proceeds from Convertible Debt	$ 217,490
Debt Instrument, Unamortized Discount	1,871,710		$ 1,920,571
Convertible Notes Payable	$ 8,120,514		$ 6,650,484
Debt Instrument, Maturity Date, Description	mature between October 2017 and March 2020 and are convertible at variable rates between 60
Debt Instrument, Convertible, Terms of Conversion Feature	convertible at variable rates between 60% and 65% of the quoted market price of the Company’s common stock
Amortization of Debt Discount (Premium)	$ 231,717	$ 239,106
Notes Payable	463,185
Debt Standstill Expense [Member] | Convertible Debt [Member]
NOTE 5: DEBT (Details) [Line Items]
Debt Instrument, Increase (Decrease), Net	$ 73,849
Minimum [Member] | Convertible Debt [Member]
NOTE 5: DEBT (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	6.00%
Maximum [Member] | Convertible Debt [Member]
NOTE 5: DEBT (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Original Issue Discount [Member] | Convertible Debt [Member]
NOTE 5: DEBT (Details) [Line Items]
Debt Instrument, Unamortized Discount	$ 182,856
Discount due to Derivative Liabilities [Member] | Convertible Debt [Member]
NOTE 5: DEBT (Details) [Line Items]
Debt Instrument, Unamortized Discount	150,471
Debt Settlement Agreement #2 [Member]
NOTE 5: DEBT (Details) [Line Items]
Interest Expense, Debt	$ 22,014
Notes from Former Affiliates [Member] | Notes Payable, Other Payables [Member]
NOTE 5: DEBT (Details) [Line Items]
Debt Instrument, Description	These notes payable of the Company are unsecured, bear no interest and are due on demand.

NOTE 6_ DERIVATIVE LIABILITIE20

NOTE 6: DERIVATIVE LIABILITIES (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability, Current	$ 8,669,572		$ 18,028,611
Derivative, Gain (Loss) on Derivative, Net	$ 8,788,332	$ 21,974,032

NOTE 6_ DERIVATIVE LIABILITIE21

NOTE 6: DERIVATIVE LIABILITIES (Details) - Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	3 Months Ended
	Mar. 31, 2017
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected dividends	0.00%
Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected term (years)	3 months
Volatility	95.00%
Risk-free rate	0.50%
Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Expected term (years)	5 years
Volatility	222.00%
Risk-free rate	1.93%

NOTE 6_ DERIVATIVE LIABILITIE22

NOTE 6: DERIVATIVE LIABILITIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis - USD ($)	Mar. 31, 2017	Dec. 31, 2016
NOTE 6: DERIVATIVE LIABILITIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative liabilities	$ 8,669,572	$ 18,028,611
Fair Value, Inputs, Level 1 [Member]
NOTE 6: DERIVATIVE LIABILITIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
NOTE 6: DERIVATIVE LIABILITIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative liabilities	0	0
Fair Value, Inputs, Level 3 [Member]
NOTE 6: DERIVATIVE LIABILITIES (Details) - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative liabilities	$ 8,669,572	$ 18,028,611

NOTE 6_ DERIVATIVE LIABILITIE23

NOTE 6: DERIVATIVE LIABILITIES (Details) - Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation	3 Months Ended
	Mar. 31, 2017USD ($)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value as of December 31, 2016	$ 18,028,611
Extinguishment of liability to additional paid-in capital	(721,178)
Change in fair value of derivatives	(8,788,332)
Fair value as of March 31, 2017	8,669,572
Derivative, Reclassified from Equity [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value on the dates of issuance recorded as debt discounts	$ 150,471

NOTE 7_ EQUITY TRANSACTIONS (De

NOTE 7: EQUITY TRANSACTIONS (Details)	3 Months Ended
	Mar. 31, 2017USD ($)shares
Stockholders' Equity Note [Abstract]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	10,546,244
Debt Conversion, Original Debt, Amount	$ 763,390
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	0
Class of Warrant or Rights, Exercisable Intrinsic Value	$ 1,702

NOTE 7_ EQUITY TRANSACTIONS (D

NOTE 7: EQUITY TRANSACTIONS (Details) - Schedule of Share-based Compensation, Stock Options, Activity - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Schedule of Share-based Compensation, Stock Options, Activity [Abstract]
Options Outstanding	685,713	685,713
Options Outstanding, Weighted Average Exercise Price	$ 4.52	$ 4.52
Options Outstanding, Weighted Average Remaining Term	2 years 135 days	2 years 226 days
Options Exercisable	685,713
Options Exercisable, Weighted Average Exercise Price	$ 4.52
Options Exercisable, Weighted Average Remaining Term	2 years 135 days
Options Granted	0
Options Granted, Weighted Average Exercise Price	$ 0
Options Expired	0
Options Expired, Weighted Average Exercise Price	$ 0
Options Exercised	0
Options Exercised, Weighted Average Exercise Price	$ 0

NOTE 7_ EQUITY TRANSACTIONS 26

NOTE 7: EQUITY TRANSACTIONS (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract]
Warrants Outstanding	7,386,920	7,314,423
Warrants Outstanding, Weighted Average Exercise Price	$ 0.41	$ 0.60
Warrants Outstanding, Weighted Average Remaining Term	2 years 324 days	3 years 43 days
Warrants Exercisable	7,386,920
Warrants Exercisable, Weighted Average Exercise Price	$ 0.41
Warrants Exercisable, Weighted Average Remaining Term	2 years 324 days
Warrants Granted	72,497
Warrants Granted, Weighted Average Exercise Price	$ 0.15
Warrants Granted, Weighted Average Remaining Term	4 years 361 days
Warrants Forfeited/Cancelled	0
Warrants Forfeited/Cancelled, Weighted Average Exercise Price	$ 0
Warrants Exercised	0
Warrants Exercised, Weighted Average Exercise Price	$ 0

NOTE 8_ SUBSEQUENT EVENTS (Deta

NOTE 8: SUBSEQUENT EVENTS (Details) - USD ($)	1 Months Ended	3 Months Ended
	Apr. 30, 2017	Mar. 31, 2017
NOTE 8: SUBSEQUENT EVENTS (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		10,546,244
Debt Conversion, Original Debt, Amount		$ 763,390
Subsequent Event [Member]
NOTE 8: SUBSEQUENT EVENTS (Details) [Line Items]
Loss Contingency, Damages Awarded, Value	$ 121,000
Convertible Notes Payable [Member] | Subsequent Event [Member]
NOTE 8: SUBSEQUENT EVENTS (Details) [Line Items]
Stock Issued During Period, Shares, New Issues	164,029
Debt Conversion, Converted Instrument, Shares Issued	1,800,000
Debt Conversion, Original Debt, Amount	$ 144,000